Table of Content

1 Chronic Myeloid Leukemia Treatment Market Overview
1.1 Product Overview and Scope of Chronic Myeloid Leukemia Treatment
1.2 Chronic Myeloid Leukemia Treatment Segment by Type
1.2.1 Global Chronic Myeloid Leukemia Treatment Market Value Comparison by Type (2024-2034)
1.2.2 Tablet
1.2.3 Solution
1.2.4 Capsule
1.3 Chronic Myeloid Leukemia Treatment Segment by Application
1.3.1 Global Chronic Myeloid Leukemia Treatment Market Value by Application: (2024-2034)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Chronic Myeloid Leukemia Treatment Market Size Estimates and Forecasts
1.4.1 Global Chronic Myeloid Leukemia Treatment Revenue 2018-2034
1.4.2 Global Chronic Myeloid Leukemia Treatment Sales 2018-2034
1.4.3 Global Chronic Myeloid Leukemia Treatment Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Chronic Myeloid Leukemia Treatment Market Competition by Manufacturers
2.1 Global Chronic Myeloid Leukemia Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Chronic Myeloid Leukemia Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Chronic Myeloid Leukemia Treatment Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Chronic Myeloid Leukemia Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chronic Myeloid Leukemia Treatment, Product Type & Application
2.7 Chronic Myeloid Leukemia Treatment Market Competitive Situation and Trends
2.7.1 Chronic Myeloid Leukemia Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chronic Myeloid Leukemia Treatment Players Market Share by Revenue
2.7.3 Global Chronic Myeloid Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chronic Myeloid Leukemia Treatment Retrospective Market Scenario by Region
3.1 Global Chronic Myeloid Leukemia Treatment Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Chronic Myeloid Leukemia Treatment Global Chronic Myeloid Leukemia Treatment Sales by Region: 2018-2034
3.2.1 Global Chronic Myeloid Leukemia Treatment Sales by Region: 2018-2023
3.2.2 Global Chronic Myeloid Leukemia Treatment Sales by Region: 2024-2034
3.3 Global Chronic Myeloid Leukemia Treatment Global Chronic Myeloid Leukemia Treatment Revenue by Region: 2018-2034
3.3.1 Global Chronic Myeloid Leukemia Treatment Revenue by Region: 2018-2023
3.3.2 Global Chronic Myeloid Leukemia Treatment Revenue by Region: 2024-2034
3.4 North America Chronic Myeloid Leukemia Treatment Market Facts & Figures by Country
3.4.1 North America Chronic Myeloid Leukemia Treatment Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Chronic Myeloid Leukemia Treatment Sales by Country (2018-2034)
3.4.3 North America Chronic Myeloid Leukemia Treatment Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chronic Myeloid Leukemia Treatment Market Facts & Figures by Country
3.5.1 Europe Chronic Myeloid Leukemia Treatment Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Chronic Myeloid Leukemia Treatment Sales by Country (2018-2034)
3.5.3 Europe Chronic Myeloid Leukemia Treatment Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chronic Myeloid Leukemia Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Chronic Myeloid Leukemia Treatment Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Chronic Myeloid Leukemia Treatment Sales by Country (2018-2034)
3.6.3 Asia Pacific Chronic Myeloid Leukemia Treatment Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Chronic Myeloid Leukemia Treatment Market Facts & Figures by Country
3.7.1 Latin America Chronic Myeloid Leukemia Treatment Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Chronic Myeloid Leukemia Treatment Sales by Country (2018-2034)
3.7.3 Latin America Chronic Myeloid Leukemia Treatment Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chronic Myeloid Leukemia Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Myeloid Leukemia Treatment Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Chronic Myeloid Leukemia Treatment Sales by Country (2018-2034)
3.8.3 Middle East and Africa Chronic Myeloid Leukemia Treatment Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chronic Myeloid Leukemia Treatment Sales by Type (2018-2034)
4.1.1 Global Chronic Myeloid Leukemia Treatment Sales by Type (2018-2023)
4.1.2 Global Chronic Myeloid Leukemia Treatment Sales by Type (2024-2034)
4.1.3 Global Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2018-2034)
4.2 Global Chronic Myeloid Leukemia Treatment Revenue by Type (2018-2034)
4.2.1 Global Chronic Myeloid Leukemia Treatment Revenue by Type (2018-2023)
4.2.2 Global Chronic Myeloid Leukemia Treatment Revenue by Type (2024-2034)
4.2.3 Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Type (2018-2034)
4.3 Global Chronic Myeloid Leukemia Treatment Price by Type (2018-2034)
5 Segment by Application
5.1 Global Chronic Myeloid Leukemia Treatment Sales by Application (2018-2034)
5.1.1 Global Chronic Myeloid Leukemia Treatment Sales by Application (2018-2023)
5.1.2 Global Chronic Myeloid Leukemia Treatment Sales by Application (2024-2034)
5.1.3 Global Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2018-2034)
5.2 Global Chronic Myeloid Leukemia Treatment Revenue by Application (2018-2034)
5.2.1 Global Chronic Myeloid Leukemia Treatment Revenue by Application (2018-2023)
5.2.2 Global Chronic Myeloid Leukemia Treatment Revenue by Application (2024-2034)
5.2.3 Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Application (2018-2034)
5.3 Global Chronic Myeloid Leukemia Treatment Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Teva Pharmaceutical Industries Ltd
6.1.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.1.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.1.3 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Product Portfolio
6.1.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.2.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.2.3 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Product Portfolio
6.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis AG Chronic Myeloid Leukemia Treatment Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Bristol-Myers Squibb Company
6.4.1 Bristol-Myers Squibb Company Corporation Information
6.4.2 Bristol-Myers Squibb Company Description and Business Overview
6.4.3 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Product Portfolio
6.4.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.5 Pfizer Inc.
6.5.1 Pfizer Inc. Corporation Information
6.5.2 Pfizer Inc. Description and Business Overview
6.5.3 Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pfizer Inc. Chronic Myeloid Leukemia Treatment Product Portfolio
6.5.5 Pfizer Inc. Recent Developments/Updates
6.6 Takeda Pharmaceutical Company Limited
6.6.1 Takeda Pharmaceutical Company Limited Corporation Information
6.6.2 Takeda Pharmaceutical Company Limited Description and Business Overview
6.6.3 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Product Portfolio
6.6.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
6.7 Innovent Biologics, Inc.
6.6.1 Innovent Biologics, Inc. Corporation Information
6.6.2 Innovent Biologics, Inc. Description and Business Overview
6.6.3 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Product Portfolio
6.7.5 Innovent Biologics, Inc. Recent Developments/Updates
6.8 Viatris Inc. (Mylan N.V.)
6.8.1 Viatris Inc. (Mylan N.V.) Corporation Information
6.8.2 Viatris Inc. (Mylan N.V.) Description and Business Overview
6.8.3 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Product Portfolio
6.8.5 Viatris Inc. (Mylan N.V.) Recent Developments/Updates
6.9 Lupin
6.9.1 Lupin Corporation Information
6.9.2 Lupin Description and Business Overview
6.9.3 Lupin Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Lupin Chronic Myeloid Leukemia Treatment Product Portfolio
6.9.5 Lupin Recent Developments/Updates
6.10 IL-YANG PHARM CO. LTD.
6.10.1 IL-YANG PHARM CO. LTD. Corporation Information
6.10.2 IL-YANG PHARM CO. LTD. Description and Business Overview
6.10.3 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Product Portfolio
6.10.5 IL-YANG PHARM CO. LTD. Recent Developments/Updates
6.11 Million Health Pharmaceuticals
6.11.1 Million Health Pharmaceuticals Corporation Information
6.11.2 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Description and Business Overview
6.11.3 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Product Portfolio
6.11.5 Million Health Pharmaceuticals Recent Developments/Updates
6.12 Celon Labs
6.12.1 Celon Labs Corporation Information
6.12.2 Celon Labs Chronic Myeloid Leukemia Treatment Description and Business Overview
6.12.3 Celon Labs Chronic Myeloid Leukemia Treatment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Celon Labs Chronic Myeloid Leukemia Treatment Product Portfolio
6.12.5 Celon Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Myeloid Leukemia Treatment Industry Chain Analysis
7.2 Chronic Myeloid Leukemia Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Myeloid Leukemia Treatment Production Mode & Process
7.4 Chronic Myeloid Leukemia Treatment Sales and Marketing
7.4.1 Chronic Myeloid Leukemia Treatment Sales Channels
7.4.2 Chronic Myeloid Leukemia Treatment Distributors
7.5 Chronic Myeloid Leukemia Treatment Customers
8 Chronic Myeloid Leukemia Treatment Market Dynamics
8.1 Chronic Myeloid Leukemia Treatment Industry Trends
8.2 Chronic Myeloid Leukemia Treatment Market Drivers
8.3 Chronic Myeloid Leukemia Treatment Market Challenges
8.4 Chronic Myeloid Leukemia Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Chronic Myeloid Leukemia Treatment Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Chronic Myeloid Leukemia Treatment Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Chronic Myeloid Leukemia Treatment Market Competitive Situation by Manufacturers in 2024
Table 4. Global Chronic Myeloid Leukemia Treatment Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Chronic Myeloid Leukemia Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Chronic Myeloid Leukemia Treatment Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Chronic Myeloid Leukemia Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Chronic Myeloid Leukemia Treatment, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Chronic Myeloid Leukemia Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chronic Myeloid Leukemia Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Chronic Myeloid Leukemia Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chronic Myeloid Leukemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Myeloid Leukemia Treatment as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chronic Myeloid Leukemia Treatment Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Chronic Myeloid Leukemia Treatment Sales by Region (2018-2023) & (K Units)
Table 18. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Region (2018-2023)
Table 19. Global Chronic Myeloid Leukemia Treatment Sales by Region (2024-2034) & (K Units)
Table 20. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Region (2024-2034)
Table 21. Global Chronic Myeloid Leukemia Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Region (2018-2023)
Table 23. Global Chronic Myeloid Leukemia Treatment Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Region (2024-2034)
Table 25. North America Chronic Myeloid Leukemia Treatment Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Chronic Myeloid Leukemia Treatment Sales by Country (2018-2023) & (K Units)
Table 27. North America Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (K Units)
Table 28. North America Chronic Myeloid Leukemia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Chronic Myeloid Leukemia Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Chronic Myeloid Leukemia Treatment Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Chronic Myeloid Leukemia Treatment Sales by Country (2018-2023) & (K Units)
Table 32. Europe Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (K Units)
Table 33. Europe Chronic Myeloid Leukemia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Chronic Myeloid Leukemia Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Chronic Myeloid Leukemia Treatment Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Chronic Myeloid Leukemia Treatment Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Chronic Myeloid Leukemia Treatment Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Chronic Myeloid Leukemia Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Chronic Myeloid Leukemia Treatment Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Chronic Myeloid Leukemia Treatment Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Chronic Myeloid Leukemia Treatment Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Chronic Myeloid Leukemia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Chronic Myeloid Leukemia Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Chronic Myeloid Leukemia Treatment Sales (K Units) by Type (2018-2023)
Table 51. Global Chronic Myeloid Leukemia Treatment Sales (K Units) by Type (2024-2034)
Table 52. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2018-2023)
Table 53. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Type (2024-2034)
Table 54. Global Chronic Myeloid Leukemia Treatment Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Chronic Myeloid Leukemia Treatment Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Type (2018-2023)
Table 57. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Type (2024-2034)
Table 58. Global Chronic Myeloid Leukemia Treatment Price (US$/Unit) by Type (2018-2023)
Table 59. Global Chronic Myeloid Leukemia Treatment Price (US$/Unit) by Type (2024-2034)
Table 60. Global Chronic Myeloid Leukemia Treatment Sales (K Units) by Application (2018-2023)
Table 61. Global Chronic Myeloid Leukemia Treatment Sales (K Units) by Application (2024-2034)
Table 62. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2018-2023)
Table 63. Global Chronic Myeloid Leukemia Treatment Sales Market Share by Application (2024-2034)
Table 64. Global Chronic Myeloid Leukemia Treatment Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Chronic Myeloid Leukemia Treatment Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Application (2018-2023)
Table 67. Global Chronic Myeloid Leukemia Treatment Revenue Market Share by Application (2024-2034)
Table 68. Global Chronic Myeloid Leukemia Treatment Price (US$/Unit) by Application (2018-2023)
Table 69. Global Chronic Myeloid Leukemia Treatment Price (US$/Unit) by Application (2024-2034)
Table 70. Teva Pharmaceutical Industries Ltd Corporation Information
Table 71. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 72. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Product
Table 74. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 75. F. Hoffmann-La Roche Ltd. Corporation Information
Table 76. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 77. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Product
Table 79. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 80. Novartis AG Corporation Information
Table 81. Novartis AG Description and Business Overview
Table 82. Novartis AG Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novartis AG Chronic Myeloid Leukemia Treatment Product
Table 84. Novartis AG Recent Developments/Updates
Table 85. Bristol-Myers Squibb Company Corporation Information
Table 86. Bristol-Myers Squibb Company Description and Business Overview
Table 87. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Product
Table 89. Bristol-Myers Squibb Company Recent Developments/Updates
Table 90. Pfizer Inc. Corporation Information
Table 91. Pfizer Inc. Description and Business Overview
Table 92. Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Pfizer Inc. Chronic Myeloid Leukemia Treatment Product
Table 94. Pfizer Inc. Recent Developments/Updates
Table 95. Takeda Pharmaceutical Company Limited Corporation Information
Table 96. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 97. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Product
Table 99. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 100. Innovent Biologics, Inc. Corporation Information
Table 101. Innovent Biologics, Inc. Description and Business Overview
Table 102. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Product
Table 104. Innovent Biologics, Inc. Recent Developments/Updates
Table 105. Viatris Inc. (Mylan N.V.) Corporation Information
Table 106. Viatris Inc. (Mylan N.V.) Description and Business Overview
Table 107. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Product
Table 109. Viatris Inc. (Mylan N.V.) Recent Developments/Updates
Table 110. Lupin Corporation Information
Table 111. Lupin Description and Business Overview
Table 112. Lupin Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Lupin Chronic Myeloid Leukemia Treatment Product
Table 114. Lupin Recent Developments/Updates
Table 115. IL-YANG PHARM CO. LTD. Corporation Information
Table 116. IL-YANG PHARM CO. LTD. Description and Business Overview
Table 117. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Product
Table 119. IL-YANG PHARM CO. LTD. Recent Developments/Updates
Table 120. Million Health Pharmaceuticals Corporation Information
Table 121. Million Health Pharmaceuticals Description and Business Overview
Table 122. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Product
Table 124. Million Health Pharmaceuticals Recent Developments/Updates
Table 125. Celon Labs Corporation Information
Table 126. Celon Labs Description and Business Overview
Table 127. Celon Labs Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Celon Labs Chronic Myeloid Leukemia Treatment Product
Table 129. Celon Labs Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Chronic Myeloid Leukemia Treatment Distributors List
Table 133. Chronic Myeloid Leukemia Treatment Customers List
Table 134. Chronic Myeloid Leukemia Treatment Market Trends
Table 135. Chronic Myeloid Leukemia Treatment Market Drivers
Table 136. Chronic Myeloid Leukemia Treatment Market Challenges
Table 137. Chronic Myeloid Leukemia Treatment Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chronic Myeloid Leukemia Treatment
Figure 2. Global Chronic Myeloid Leukemia Treatment Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Chronic Myeloid Leukemia Treatment Market Share by Type in 2024 & 2034
Figure 4. Tablet Product Picture
Figure 5. Solution Product Picture
Figure 6. Capsule Product Picture
Figure 7. Global Chronic Myeloid Leukemia Treatment Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Chronic Myeloid Leukemia Treatment Market Share by Application in 2024 & 2034
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Chronic Myeloid Leukemia Treatment Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Chronic Myeloid Leukemia Treatment Market Size (2018-2034) & (US$ Million)
Figure 14. Global Chronic Myeloid Leukemia Treatment Sales (2018-2034) & (K Units)
Figure 15. Global Chronic Myeloid Leukemia Treatment Average Price (US$/Unit) & (2018-2034)
Figure 16. Chronic Myeloid Leukemia Treatment Report Years Considered
Figure 17. Chronic Myeloid Leukemia Treatment Sales Share by Manufacturers in 2024
Figure 18. Global Chronic Myeloid Leukemia Treatment Revenue Share by Manufacturers in 2024
Figure 19. The Global 5 and 10 Largest Chronic Myeloid Leukemia Treatment Players: Market Share by Revenue in 2024
Figure 20. Chronic Myeloid Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 21. Global Chronic Myeloid Leukemia Treatment Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 22. North America Chronic Myeloid Leukemia Treatment Sales Market Share by Country (2018-2034)
Figure 23. North America Chronic Myeloid Leukemia Treatment Revenue Market Share by Country (2018-2034)
Figure 24. United States Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Chronic Myeloid Leukemia Treatment Sales Market Share by Country (2018-2034)
Figure 27. Europe Chronic Myeloid Leukemia Treatment Revenue Market Share by Country (2018-2034)
Figure 28. Germany Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Chronic Myeloid Leukemia Treatment Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Chronic Myeloid Leukemia Treatment Revenue Market Share by Region (2018-2034)
Figure 35. China Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. China Taiwan Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Chronic Myeloid Leukemia Treatment Sales Market Share by Country (2018-2034)
Figure 45. Latin America Chronic Myeloid Leukemia Treatment Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Chronic Myeloid Leukemia Treatment Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Chronic Myeloid Leukemia Treatment by Type (2018-2034)
Figure 55. Global Revenue Market Share of Chronic Myeloid Leukemia Treatment by Type (2018-2034)
Figure 56. Global Chronic Myeloid Leukemia Treatment Price (US$/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Chronic Myeloid Leukemia Treatment by Application (2018-2034)
Figure 58. Global Revenue Market Share of Chronic Myeloid Leukemia Treatment by Application (2018-2034)
Figure 59. Global Chronic Myeloid Leukemia Treatment Price (US$/Unit) by Application (2018-2034)
Figure 60. Chronic Myeloid Leukemia Treatment Value Chain
Figure 61. Chronic Myeloid Leukemia Treatment Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed